Navigation Links
Genetic variant linked to odor perception
Date:9/16/2007

DURHAM, N.C. Why the same sweaty man smells pleasant to one person and repellant to another comes down to the smellers genes.

Duke University Medical Center researchers demonstrated that genetic variants of odor receptors within the nose determine how a particular odor is perceived. The researchers, led by Dukes Hiroaki Matsunami, Ph.D., assistant professor of molecular genetics and microbiology, published the results of their experiments early online Sept. 16 in the journal Nature.

The researchers focused on two chemicals androstenone and androstadienone that are created naturally by the body during the breakdown of the male sex hormone testosterone and are excreted in sweat and urine.

We found that genetic variations of a specific odor receptor determine, to a significant degree, why the same chemicals smell pleasant or unpleasant to different people, Matsunami said. These results demonstrate the first link between the functioning of a human odor receptor gene and how that odor is perceived.

Humans have about 400 odor receptors within the nose that detect various odors or chemicals. Smells typically bind to their corresponding receptors, and the information is then relayed to the brain for processing.

The researchers wanted to uncover the reasons why people react differently when they smell these two sex steroid-derived chemicals. Hanyi Zhuang, a student in the Matsunami laboratory, tested all the known smell receptors in the laboratory and found one that reacted strongly with the two chemicals.

In conjunction with their collaborators at Rockefeller University, the researchers asked 391 volunteers to inhale the two chemicals and describe what they smelled. The results ranged from no smell at all, to descriptions such as vanilla and sweet and sickening and urine. DNA extracted from blood samples from each volunteer were sent to Matsunamis laboratory.

After performing genetic analysis on each of
'/>"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Mouse brain tumors mimic those in human genetic disorder
5. Genetically modified natural killer immune cells attack, kill leukemia cells
6. Scientists identify genetic pathways essential to RNA interference
7. Ants Genetic Engineering Leads To Species Interdependency
8. Researchers trace evolution to relatively simple genetic changes
9. Genetic Variation Visualization - From EMBL
10. Genetically modified rice in China benefits farmers health, study finds
11. Key mechanism in genetic inheritance during cell division identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... The announcement comes as demand for fire vault ... Ireland,s foremost records management company, has secured ... impressive track record of clients within the first 12 months, ... sector in Dubai . As a result, ... a further eight staff members at its Irish headquarters. The ...
(Date:4/13/2015)... NEW YORK , April 13, 2015 /PRNewswire/ ... study by TechSci Research, "Global Biometrics Market Forecast & ... to register a CAGR of around 14% till ... various governments for large scale implementation and review ... technology and launch of new products with greater ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... male birds attract more females and as a result are ... point of many studies looking for factors that influence sexual ... birds see what we see? In a study published in ... our human vision is not an adequate instrument. The ...
... the late 19th century the Czech scientist Franz Hofmeister ... of proteins in egg white, some caused the proteins ... between these poles. Hofmeister proceeded to rank ... magnitude of their effects. The resulting "Hofmeister series" governs ...
... release is available in Spanish . ... but somebody, or at least some dogs, have to do ... trained to detect animal feces by scent are helping researchers ... anteater and maned wolf in and around Emas National Park, ...
Cached Biology News:Human vision inadequate for research on bird vision 2New clues to how proteins dissolve and crystallize 2New clues to how proteins dissolve and crystallize 3New clues to how proteins dissolve and crystallize 4Can feces save the species? 2Can feces save the species? 3
(Date:5/22/2015)... 2015  Actavis plc (NYSE: ACT ) today ... Appeals for the Second Circuit has issued a ruling ... Company to continue distribution of NAMENDA ® (memantine ...   "While we are disappointed by ... to continue our strong efforts to convey the significant ...
(Date:5/21/2015)... , May 21, 2015 /PRNewswire/ - SQI Diagnostics ... life sciences company that develops and commercializes proprietary technologies ... financial and operational results for the second fiscal quarter ... quarter the Company continued to advance business with our ... Andrew Morris , President and CEO of SQI. "The ...
(Date:5/21/2015)... May 21, 2015 uBiome, the ... a partnership with PicnicHealth, a healthcare company that ... diagnosed with Inflammatory Bowel Disease (IBD) will receive ... complementary uBiome research kit. Both companies were funded ... , For more information on this partnership ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
... Bulletin Board: SNKTY), a Life Sciences company engaged in ... aging, today,announced that shareholders have approved all four resolutions ... of Shareholders held on,December 16, 2008. , ... results of the voting and we thank our,shareholders for ...
... Isis Pharmaceuticals,Inc. (Nasdaq: ISIS ) announces the following webcast: , , ... a subsidiary of Isis. Total acquisition price ... When: Wednesday, December 17, 2008 at 8:30 a.m. ET / ... Live on the Internet. Simply log onto our Web site listed, ...
... retina cells or other tissues can be tracked by ... record of movement and gene expression. The new technique, ... , will allow detailed analyses of correlations between behavior, ... team of researchers from the University of Southern California, ...
Cached Biology Technology:Senetek PLC Announces 2008 Annual General Meeting Voting Results 2Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences 2
MOUSE ANTI HUMAN B-CELLS (FMC7):FITC Immunogen: HRIK cells - Human B-Lymphoblastoid line...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
2,4-Dinitrophenyl hapten is conjugated to BSA (Bovine Serum Albumin) protein through lysine....
GOAT ANTI HUMAN FACTOR 8RELATED ANTIGEN...
Biology Products: